Real-time enrollment status for this metastatic castration-resistant prostate cancer (crpc) clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 5:46 AM UTC
| NCT Number | NCT06705686 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Castration-resistant Prostate Cancer (CRPC) |
| Phase | PHASE1 |
| Target Enrollment | 40 participants |
| Active Locations | 1 sites in the US |
| Sponsor | TechnoGenesys, Inc. |
| Last Updated on CT.gov | March 20, 2026 (Mar 20, 2026) |
As of July 19, 2026: Clinical trial NCT06705686 is currently recruiting participants. This phase1 study for metastatic castration-resistant prostate cancer (crpc) is actively seeking new participants at 1 location across the United States. The study is sponsored by TechnoGenesys, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06705686 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06705686 was last updated Mar 20, 2026 (March 20, 2026). HelloStudys verifies this status automatically.